$4.67
0.000.00%
Pre-Market: 8:59 AM EDT
Comments
Loading...
4D Molecular Therapeutics (FDMT) Forecast
NewsEarnings4D Molecular Therapeutics (FDMT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest4D Molecular Therapeutics (NASDAQ:FDMT) Stock Quotes, Forecast and News Summary
4D Molecular Therapeutics Stock (NASDAQ: FDMT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy 4D Molecular Therapeutics (FDMT) stock?
You can purchase shares of 4D Molecular Therapeutics (NASDAQ:FDMT) through any online brokerage.
Who are 4D Molecular Therapeutics (FDMT) competitors?
Other companies in 4D Molecular Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Voyager Therapeutics (NASDAQ:VYGR), Monopar Therapeutics (NASDAQ:MNPR), Larimar Therapeutics (NASDAQ:LRMR) and Sangamo Therapeutics (NASDAQ:SGMO).
What is the forecast, or price target, for 4D Molecular Therapeutics (FDMT) stock?
4D Molecular Therapeutics has a consensus price target of $36.25.
What is the current price for 4D Molecular Therapeutics (FDMT)?
The stock price for 4D Molecular Therapeutics (NASDAQ: FDMT) is $4.67 last updated February 21, 2025 at 8:59 AM EST.
Does 4D Molecular Therapeutics (FDMT) pay a dividend?
There are no upcoming dividends for 4D Molecular Therapeutics.
When is 4D Molecular Therapeutics (NASDAQ:FDMT) reporting earnings?
4D Molecular Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is 4D Molecular Therapeutics (FDMT) going to split?
There is no upcoming split for 4D Molecular Therapeutics.
What sector and industry does 4D Molecular Therapeutics (FDMT) operate in?
4D Molecular Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.